Response to Dr. Norman W. Baylor's Letter to the Editor entitled: "Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax"

Michael N. Oxman, Anne A. Gershon, Gregory A. Poland

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)8772
Number of pages1
JournalVaccine
Volume29
Issue number48
DOIs
StatePublished - Nov 8 2011

Fingerprint

Herpes Zoster Vaccine
Pneumococcal Vaccines
United States Food and Drug Administration

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Response to Dr. Norman W. Baylor's Letter to the Editor entitled : "Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax". / Oxman, Michael N.; Gershon, Anne A.; Poland, Gregory A.

In: Vaccine, Vol. 29, No. 48, 08.11.2011, p. 8772.

Research output: Contribution to journalArticle

@article{488f231de9eb4d6484523572944310c1,
title = "Response to Dr. Norman W. Baylor's Letter to the Editor entitled: {"}Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax{"}",
author = "Oxman, {Michael N.} and Gershon, {Anne A.} and Poland, {Gregory A.}",
year = "2011",
month = "11",
day = "8",
doi = "10.1016/j.vaccine.2011.08.052",
language = "English (US)",
volume = "29",
pages = "8772",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "48",

}

TY - JOUR

T1 - Response to Dr. Norman W. Baylor's Letter to the Editor entitled

T2 - "Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax"

AU - Oxman, Michael N.

AU - Gershon, Anne A.

AU - Poland, Gregory A.

PY - 2011/11/8

Y1 - 2011/11/8

UR - http://www.scopus.com/inward/record.url?scp=82455209003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455209003&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.08.052

DO - 10.1016/j.vaccine.2011.08.052

M3 - Article

AN - SCOPUS:82455209003

VL - 29

SP - 8772

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 48

ER -